TY - JOUR
T1 - Signaling in malignant astrocytomas
T2 - Role of neural stem cells and its therapeutic implications
AU - Alcantara Llaguno, Sheila R.
AU - Chen, Jian
AU - Parada, Luis F.
PY - 2009/12/1
Y1 - 2009/12/1
N2 - Malignant astrocytomas are infiltrative and aggressive brain tumors. Conventional forms of therapy have not been effective in controlling this incurable disease. Recent advances in understanding the molecular biology of these tumors have revealed potential mechanisms by which astrocytoma cells undergo tumor initiation, progression, and maintenance, as well as possible avenues for targeted therapeutics. Studies on the role of neural stem cells as cells of origin and tumor-propagating cells have also greatly increased our understanding of the biology and clinical behavior of these tumors. An integrated view of the genetics, signal transduction, and cell biology of astrocytomas, as well as clinical data from patients, will provide a more useful approach in designing novel therapies for this devastating disease.
AB - Malignant astrocytomas are infiltrative and aggressive brain tumors. Conventional forms of therapy have not been effective in controlling this incurable disease. Recent advances in understanding the molecular biology of these tumors have revealed potential mechanisms by which astrocytoma cells undergo tumor initiation, progression, and maintenance, as well as possible avenues for targeted therapeutics. Studies on the role of neural stem cells as cells of origin and tumor-propagating cells have also greatly increased our understanding of the biology and clinical behavior of these tumors. An integrated view of the genetics, signal transduction, and cell biology of astrocytomas, as well as clinical data from patients, will provide a more useful approach in designing novel therapies for this devastating disease.
UR - http://www.scopus.com/inward/record.url?scp=73149118890&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=73149118890&partnerID=8YFLogxK
U2 - 10.1158/1078-0432.CCR-09-0433
DO - 10.1158/1078-0432.CCR-09-0433
M3 - Article
C2 - 19934302
AN - SCOPUS:73149118890
SN - 1078-0432
VL - 15
SP - 7124
EP - 7129
JO - Clinical Cancer Research
JF - Clinical Cancer Research
IS - 23
ER -